Methacholine and adenosine 5′-monophosphate challenges in preschool children with cough-variant and classic asthma

Pediatric Pulmonology

Volumn 42, Issue 10, 2007, Pages 973-979

  Bakirtas, Arzu ^a,c   Turktas, Ipek ^a,b  

^a GAZI UNIVERSITY   (Turkey)

^b Department of Medicine ^*

^c GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Adenosine; Airway hyperresponsiveness; Asthma; Cough variant asthma; Preschool

Indexed keywords

ADENOSINE PHOSPHATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; SALBUTAMOL; STEROID; THEOPHYLLINE;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; COUGHING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN TENSION; PRESCHOOL CHILD; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; TRANSCUTANEOUS OXYGEN MONITORING;

ADENOSINE MONOPHOSPHATE; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTOR AGENTS; CHILD; CHILD, PRESCHOOL; COUGH; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; METHACHOLINE CHLORIDE; PROSPECTIVE STUDIES;

EID: 35148886030     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20692     Document Type: Article

References (38)

1. Marchant JM, Masters BI, Taylor SM, Cox NC, Seymour GJ, Chang AB. Evaluation and outcome of young children with chronic cough. Chest 2006;129:1132-11341.
2. Todokoro M, Mochizuki H, Tokuyama K, Morikawa A. Childhood cough variant asthma and its relationship to classic asthma. Ann Allergy Asthma Immunol 2003;90:652-659.
3. Mochizuki H, Arakawa H, Tokuyama K, Morikawa A. Bronchial sensitivity and bronchial reactivity in children with cough variant asthma. Chest 2005;128:2427-2434.
4. Boulet LP, Belanger M, Carrier G. Airway responsiveness and bronchial wall thickness in asthma with or without fixed airflow obstruction. Am J Respir Crit Care Med 1995;152:865-871.
5. 20 methacholine. Am J Respir Crit Care Med 2001;163:1546-1550.
6. Avital A, Springer C, Bar-Yishay E, Godfrey S. Adenosine, metacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax 1995;50:511-516.
7. Yoo Y, Koh YY, Kang H, Yu J, Nah KM, Kim CK. Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine. Allergy 2004;59:1055-1062.
8. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J 1998;11:1064-1069.
9. Niimi A, Chung KF. Airway inflammation and remodelling changes in patients with chronic cough: do they tell us about the cause of cough? Pulm Pharmacol Ther 2004;17:441-446.
10. Niimi A, Matsumoto H, Minakuchi M, Kitaichi M, Amitani R. Airway remodelling in cough-variant asthma. Lancet 2000;356:564-565.
11. Godfrey S, Cohen S, Avital A, Springer C. Timing and nature of wheezing at the end point of a bronchial challenge in preschool children. Pediatr Pulmonol 2005;39:262-267.
12. Phagoo SB, Wilson NM, Silvermenn M. Repeatability of metacholine challenge in asthmatic children measured by change in transcutaneous oxygen tension. Thorax 1992;47:804-808.
13. American Thoracic Society. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000;161:309-329.
14. Avital A, Godfrey S, Springer C. Exercise, methacholine, and adenosine 5′-monophosphate challenges in children with asthma: relation to severity of disease. Pediatr Pulmonol 2000;30:207-214.
15. Fowler SJ, Dempsey OJ, Sims EJ, Lipworth BJ. Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Am J Respir Crit Care Med 2000;162:1318-1322.
16. Koh YY, Chae SA, Mim KU. Cough variant asthma is associated with a higher wheezing threshold than classic asthma. Clin Exp Allergy 1993;23:696-701.
17. Koh YY, Jeong JH, Park Y, Kim CK. Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness. Eur Respir J 1999;14:302-308.
18. Koh YY, Park Y, Kim CK. The importance of maximal airway response to methacholine in the prediction of wheezing development in patients with cough-variant asthma. Allergy 2002;57:1165-1170.
19. Kim CK, Kim JT, Kang H, Yoo Y, Koh YY. Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma. Clin Exp Allergy 2003;33:1409-1414.
20. Sacha RF, Trembley NF, Jacobs RL. Chronic cough, sinusitis, and hyperreactive airways in children; an often overlooked association. Ann Allergy 1985;54:195-198.
21. Bakirtas A, Turktas I. Airway hyper-responsiveness to adenosine 5′-monophosphate in preschool-age children with asthma. Pediatr Allergy Immunol 2006;17:428-434.
22. Kim DK, Choi SH, Yu J, Yoo Y, Koh YY. Bronchial responsiveness to methacholine and adenosine 5′-monophospate in atopic and non-atopic preschool children with recurrent wheezing. Clin Exp Allergy 2007;37:15-21.
23. Doull IJM, Sandal D, Smith S, Schreiber J, Freezer NJ, Holgate ST. Differential inhibitory effect of regular inhaled corticosteroid on airway responsiveness to adenosine 5′-monophosphate, metacholine, and bradykinin in symptomatic children with recurrent wheeze. Pediatr Pulmonol 1997;23:404-411.
24. Avital A, Godfrey S, Springer C. Exercise, metacholine, and adenosine 5′-monophosphate challenges in children with asthma: relation to severity of the disease. Pediatr Pulmonol 2000;30:207-214.
25. 20 of metacholine. Am J Respir Crit Care Med 2001;164:1127-1132.
26. Holgate ST, Beasley R, Twentyman OP. The pathogenesis and significance of bronchial hyper-responsiveness in airways disease. Clin Sci 1987;73:561-572.
27. Joos GF, O'Connor B. ERS Task Force Indirect airway challenges. Eur Respir J 2003;21:1050-1068.
28. van Schoor J, Pauwels R, Joos G. Indirect bronchial hyper-responsiveness: the coming of age of a specific group of bronchial challenges. Clin Exp Allergy 2005;35:250-261.
29. Fitch PS, Brown V, Schock BC, Taylor R, Ennis M, Shields MD. Chronic cough in children: bronchoalvelar lavage findings. Eur Respir J 2000;16:1109-1114.
30. Chatkin JM, Ansarin K, Silkoff PE, McClean P, Gutierrez C, Zamel N, Chapman KR. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med 1999;159:1810-1813.
31. Okada C, Horiba M, Matsumoto H, Torigoe R, Mizuuchi H, Murao M, Soda R, Takahashi K, Kimura G, Tanimoto Y. A study of clinical features of cough variant asthma. Int Arch Allergy Immunol 2001;125:51-54.
32. de Diego A, Martinez E, Perpiná M, Nieto L, Compte L, Marián V, Senent L. Airway inflammation and cough sensitivity in cough-variant asthma. Allergy 2005;60:1407-1411.
33. Saglani S, Bush A. The early-life origins of asthma. Curr Opin Allergy Clin Immunol 2007;7:83-90.
34. Saglani S, Malmström K, Pelkonen AS, Malmberg LP, Lindahl H, Kajosaari M, Turpeinen M, Rogers AV, Payne DN, Bush A, Haahtela T, Makela MJ, Jeffery PK. Airway remodelling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722-727.
35. ten Hacken NH, Timens W, Smith M, Drok G, Kraan J, Postma DS. Increased peak expiratory flow variation in asthma: severe persistent increase but not nocturnal worsening of airway inflammation. Eur Respir J 1998;12:546-550.
36. 20AMP in asthma and COPD. Respir Med 2007;101:882-887.
37. Polosa R. Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease. Eur Respir J 2002;20:488-496.
38. Ramsdell JW. Adenosine airways responsiveness: what does it mean? Chest 2003;123:971-973.